Standard Operating Procedure

Size: px
Start display at page:

Download "Standard Operating Procedure"

Transcription

1 SOP number: Standard Operating Procedure SOP-JRO SOP full title: Consent and Sample Tracking for Samples Collected for the Newcastle Biomedicine Research Tissue Bank (REC no. 12/NE/0395) SOP effective: 16 September 2013 Review date: 16 September 2015 SOP author signature: SIGNED COPY KEPT IN THE JRO Mhairi Anderson, Quality Assurance Manager, Newcastle Biomedicine Biobank, Newcastle University SOP approval signatures: SIGNED COPY KEPT IN THE JRO Professor Andy Hall, Designated Individual, Research HTA licence (Ref ) Newcastle University SIGNED COPY KEPT IN THE JRO Susan Ridge, Research Governance Manager, The Newcastle upon Tyne Hospitals NHS Foundation Trust SOP HISTORY Version Date Reason for change 1. BACKGROUND/INTRODUCTION The Newcastle University and The Newcastle Upon Tyne Hospitals NHS Foundation Trust (NUTH FT) Standard Operating Procedures (SOPs) are designed to ensure that research, and its supporting activities, is carried out in accordance with the principles of Good Clinical Practice (GCP) and the Human Tissue Act (2004) (HTA). The HTA requires that all donated tissue held in a biobank can be tracked to an original consent form. SOP Template Version 1.1, Page 1 of 13 SOP-JRO

2 2. PURPOSE The purpose of this SOP is to provide instructions for all staff responsible for the collection and management of samples and associated clinical data into the Newcastle Biomedicine Research Tissue Bank (NBRTB) (REC no. 12/NE/0395). All staff operating under this research tissue bank must read this document before undertaking this procedure. The aim is of this SOP is to ensure compliance with the terms and conditions set out in the approval of the tissue bank, and the HTA and GCP requirements for consent and sample tracking. It should be noted that consent and sample tracking for other research tissue banks and individual studies may be managed differently and it is the responsibility of all staff to ensure that they are appropriately trained before commencing this procedure. 3. SCOPE This SOP applies to all staff responsible for the collection and management of samples into the Newcastle Biomedicine Research Tissue Bank (NBRTB) (REC no. 12/NE/0395). This includes staff working as part of the Clinical Research Directorate, as part of NUTH FT, and staff working under the remit of the Newcastle Biomedicine Biobank, as part of Newcastle University. Samples may be collected for: External researchers (i.e. commercial partners) researchers who are not employed by Newcastle University or do not hold an honorary contract with Newcastle University, or, Internal researchers researchers employed by Newcastle University, or those holding an honorary contract with Newcastle University. All staff involved in taking consent must also read Guidance for professionals taking consent for research tissue banks located on the Newcastle Joint Research Office website at the following address: 4. PROCEDURE 4.1. Application Process The application process to receive samples under the ethical approval granted to the Newcastle Biomedicine Research Tissue Bank (NBRTB) for both external and internal researchers is described below and summarised in Appendix External Researchers SOP Template Version 1.1, Page 2 of 13 SOP-JRO

3 External researchers who wish to receive samples for use in research will contact Newcastle University or NUTH FT. Researchers will be referred to the appropriate on-line application form. The external researcher will complete the on-line application form. All projects will be assigned a unique project number by the online application form, marked as EXT to highlight that the project is for External researchers (e.g. 001-EXT). On receipt of the completed on-line application form a provisional quote will be sent to the researcher by Research and Enterprise Services (RES) at Newcastle University. The request for samples will be reviewed for suitability and feasibility by the NBRTB access committee within 4-6 weeks of receipt. In parallel, RES will conduct due diligence on the external researcher to assess their suitability as a collaborator and compile a detailed costing of the proposed project. The NBRTB access committee and RES will then review the results to determine if the application has been successful. Where requests are successful, the external researcher will be contacted and the terms of the agreement negotiated by RES, including agreement on the minimum data set required for the study, where appropriate. RES will complete the appropriate Material Transfer Agreement including the agreed project details (e.g. samples, data, timeframe) as an appendix. The MTA will be sent to the external researcher for approval. This will be referred to later in the clinic as the project protocol. For unsuccessful applications the external researcher will be informed by RES Internal Researchers All requests from internal researchers to collect samples under the NBRTB should be captured using the appropriate on-line application form. All projects will be assigned a unique project number by the online application form, marked as INT to highlight that the project is for Internal researchers (e.g. 001-INT). Requests for samples will be reviewed under the terms of the research ethics approval, feasibility and scientific merit by the NBRTB access committee. SOP Template Version 1.1, Page 3 of 13 SOP-JRO

4 4.2. Study Set Up Researchers will be informed if their application has been successful by the access committee. For all approved projects under the NBRTB, a Biobank Manager will be assigned at the discretion of the Designated Individual (DI) to manage the project. The Biobank Manager (or delegate) will set up a Project Master File containing the following documents: 1. Copy of regulatory approvals including o Integrated Research Applications System (IRAS) application form o IRAS approval letter for the research tissue bank o Newcastle Biomedicine Biobank Research Protocol 2. Copy of the contract (for external researchers only) i.e. the Material Transfer Agreement (MTA) prepared by RES between Newcastle University and the client. 3. Copy of the minimum data set required for the study and any preagreed questionnaire to be completed in the clinic (where appropriate). 4. Contact details: A list of contact details including the researcher, Biobank Manager and contacts in the clinic. 5. Copy of the Service Level Agreement (SLA) covering the transfer of the samples between NUTH FT and Newcastle University and a blank copy of the Sample Transfer and Release Form under REC 12/NE/0395) see Appendix 7.1. A blank editable copy of this form can be found on the Newcastle Joint Research Office website at the following link: 6. A link to the relevant procedures that must be followed (e.g. SOPs, Guidance for Professionals Discussing Consent) Each project within the NBRTB will receive a set of sequentially numbered consent forms from the DI. The Biobank Manager (or delegate) will create a log of the consent form numbers assigned to the project, and write the NBRTB project number on each consent form. SOP Template Version 1.1, Page 4 of 13 SOP-JRO

5 Each Clinical Site involved in taking consent for the project will be assigned a batch of consent forms from this set. For each batch the consent form will be labelled with an alphabetic code after the NBRTB project number to indicate which clinic the consent form has been assigned to. The alphabetic codes to be used for each site are provided in table 1. Table 1: Codes for Clinical Sites Code R F G C W Clinical Site Royal Victoria Infirmary Freeman Hospital Centre for Ageing and Vitality (old General Hospital) Centre for Life Walker Gate e.g. Project 001-EXT with consent taken at the Freeman Hospital = 001-EXT- F Consent forms and the consent form log will be added to the Project Master File. The Biobank Manager will then send each Clinical Site involved in the project with a replica of the Project Master File (known as the Project Site File) containing the batch of original numbered consent forms assigned to that clinical site for the project. The Project Master File will be retained by the Biobank Manager. Clinical staff will then add any site specific contents to the Project Site File e.g. CVs for staff involved in the study, GCP training certificates etc Sample Collection Patients will be consented according to the procedure set out in Guidance for Professionals Taking Consent for Research Tissue Banks accessed on the Newcastle Joint Research Office website - All participants will be allocated a unique patient number comprising the project number, first and last initial and sequential 3 digit number beginning 001 (e.g. project 001-EXT, with consent taken at the Freeman Hospital, first patient John Smith = 001-EXT-F-JS This number will be added to the consent form by the clinical staff member). Three photocopies of the consent form will be taken: - The original consent form will be stored in the Project Site File. - One copy will be stored in the patient notes. SOP Template Version 1.1, Page 5 of 13 SOP-JRO

6 - One copy will be given to the patient. - One copy will be sent to the appropriate Biobank Manager at Newcastle University on transfer of the samples. All samples taken from a patient will be identified on the sample label with the unique patient number plus an alphabetical code beginning A to identify the sample number from the same patient (i.e. blood specimen 2 will be 001- EXT-F-JS-001B see figure 1). Additionally the date of collection will be added to the specimen container. 001 EXT F JS 001 B Sample number taken from that patient B=sample 2 Project number 1 for an external researcher Initials of patient e.g. John Smith Sequential 3 digit number Freeman Hospital is location of site file Figure 1: Example sample label Prior to release, the clinical team should complete section A of the Sample Transfer and Receipt Under REC 12/NE/0395 form see Appendix 7.1. Copies of this form should be made available in the Project Site File, and editable electronic copies can also be accessed via the Newcastle Joint Research Office website: Sample Transfer to Newcastle University Samples will be transferred to the Biobank Manager along with any associated data, a copy of the signed consent form and the Sample Transfer and Receipt Under REC 12/NE/0395 form with section A completed. Consent forms should be enclosed in a sealed envelope with the label: CONFIDENTIAL INFORMATION ENCLOSED SHOULD ONLY BE OPENED BY AUTHORISED INDIVIDUALS HOLDING AN APPROPRIATE CONTRACT SOP Template Version 1.1, Page 6 of 13 SOP-JRO

7 Upon receipt: Section B of the Sample Transfer and Receipt form (Appendix 7.1.) should be completed by the Biobank Manager (or delegate). The clinical staff sending the samples should be contacted to confirm that all samples and associated data have been received in good condition, and a photocopy of the completed Sample Transfer and Receipt Under REC 12/NE/0395 form sent to them for their records. The original form should be stored in the Project Master File. Where there is discrepancy in the samples received, or samples are not received in a good condition, the clinic should be contacted using the contact details provided in the Project Master File. Samples will be placed in the relevant freezer for the study and sample tracking system updated to accurately record the location of the sample (e.g. freezer number, shelf number). The signed consent form will be stored securely and sample receipt records and the sample tracking system updated to record all sample and consent information. When adding the sample details to the sample tracking database the Biobank Manager must check the patient/sample number is unique. In instances where it is believed that a patient/sample number has been duplicated, the clinic will be informed immediately and a new number assigned Sample Release Samples will be stored in an appropriate Biobank until required by the researcher (as agreed with the Biobank Manager). When it is required to transfer samples, the Biobank Manager will release the samples in line with local procedures. Samples transferred to external researchers will be transferred under the appropriate MTA. Any associated paperwork will be added to the Project Master File Sample Disposal Where it is necessary to destroy any samples this will be done in accordance with local SOPs and Newcastle Biomedicine Biobank (NBB) disposal policy, which can be found on the NBB website: End of Project At the end of the project any unused consent forms should be returned to the Biobank Manager. The Biobank Manager should contact RES to inform them that the project is complete and the Project Site File and Project Master File should be archived in accordance with local procedures. This procedure is summarised in Appendix 7.3. SOP Template Version 1.1, Page 7 of 13 SOP-JRO

8 5. REVIEW AND MONITORING OF THIS DOCUMENT This document will be reviewed every 2 years or if there is a change to the national guidance/regulations. 6. REFERENCES 6.1. The Human Tissue Act HTA Code of Practice 9 Research - research.cfm 6.3. The Newcastle Joint Research Office Website, Human Tissue Section APPENDICES 7.1. Sample Transfer and Release Form under REC 12/NE/ Application Process under the Newcastle Biomedicine Research Tissue Bank 7.3. Consent and Sample Tracking Procedure under the Newcastle Biomedicine Research Tissue Bank SOP Template Version 1.1, Page 8 of 13 SOP-JRO

9 7.1. Sample Transfer and Release Form under REC 12/NE/0395 An editable version of this form can be found on the human tissue section of the Newcastle Joint Research Office website. SOP Template Version 1.1, Page 9 of 13 SOP-JRO

10 SOP Template Version 1.1, Page 10 of 13 SOP-JRO

11 SOP Template Version 1.1, Page 11 of 13 SOP-JRO

12 7.2. Application Process under the Newcastle Biomedicine Research Tissue Bank EXTERNAL RESEARCHER (i.e. commercial partner) External researcher contacts Newcastle University or NHS Trust to request prospective sample collection for research. INTERNAL RESEARCHER (i.e. employed by Newcastle University, or holding an honorary contract) Internal researcher requests prospective sample collection for research. Researcher referred to the Newcastle University online application form Researcher referred to the Newcastle University on-line application form External researcher completes on-line application form which is assigned a unique project number including the letter EXT to indicate External The request is received by the Access Committee and RES for review RES add the application to MyProjects and identify appropriate clinician/surgeon to determine if the work is feasible and generate an indicative quote for the application (via NHS and Central Biobank) Internal researcher completes on-line application form for internal researchers which is assigned a unique project number including the letters INT to indicate Internal The request is received by the Access Committee for review Access committee inform internal researcher on the outcome of their application Provisional quote sent to external researcher for review Provisional quote agreed Provisional quote rejected by researcher & application process stopped. Application reviewed for feasibility and scientific merit by the NBRTB Access Committee RES conduct due diligence on the external researchers suitability as a commercial partner and conduct a detailed costing of the approved project Review of Access Committee & RES results to determine if the application has been successful RES inform external researcher on the outcome of their application within 4-6 weeks. Successful application Unsuccessful application - STOP Successful application MTA sent to researcher with final costing and terms and conditions in an appendix SOP Template Version 1.1, Page 12 of 13 SOP-JRO

13 7.3. Consent and Sample Tracking Procedure under the Newcastle Biomedicine Research Tissue Bank Successful application Newcastle University Newcastle Upon Tyne Hospitals NHS Foundation Trust Designated Individual (DI) assigns a Biobank Manager to the Project and provides them with a set of numbered consent forms for the study Biobank Manager sets up Project Master File and creates a log of the numbered consent forms assigned to the study Biobank Manager writes the Project number on each consent form and assigns a batch to each Clinical Site involved in the study. An alphabetic code for that site is added to the consent form after the Project number The Biobank Manager creates a copy of the Project Master File for each Clinical Site (called the Project Site File) and sends this to the Clinic along with the batch of assigned consent forms Project Site File received by each Clinical Site for the Project containing batch of consent forms assigned for that site. Site specific documents are added to the file e.g. CVs for staff, GCP certificates Patients consented by Clinical Staff according to the procedure set out in Guidance for professionals discussing consent with adult patients Patients allocated a unique patient number (comprising project number-location of project site file-first and last initial-sequential 3 digit number beginning 001) and patient number added to the consent form Three copies of the consent form taken and original form stored in Project Site File. Sample collection Sample receipt by Biobank Manager and Part B of Sample Transfer and Receipt for the NBRTB form completed and added to the Project Master File Consent form checked against sample tracking database to ensure that patient number is unique & form added to the Project Master File. Sample labelled with unique patient number and alphabetical code beginning A to identify the sample number from the same patient Part A of Sample Transfer and Receipt for the NBRTB form completed and sample sent to Biobank Manager with any pre-agreed data, a copy of the consent form in a sealed, labelled envelope Where appropriate, samples added to appropriate freezer and sample tracking system updated with storage location and sample details Samples released to researchers according to local sample release procedures End of project. Unused consent forms requested from clinic, and Project Master File archived Unused consent forms returned to the Biobank Manager and Project Site File archived. SOP Template Version 1.1, Page 13 of 13 SOP-JRO

Study Files and Filing

Study Files and Filing Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm

More information

Human Samples in Research

Human Samples in Research Human Samples in Research Import and Export of Human Tissue Document Identifier HTA-06-SOP-Import and Export AUTHOR APPROVER EFFECTIVE DATE: Name and role Signature and date Name and role Signature and

More information

UNIVERSITY OF LEICESTER STANDARD OPERATING PROCEDURES. University of Leicester (UoL) Research Governance Office HTA-1006-UoL

UNIVERSITY OF LEICESTER STANDARD OPERATING PROCEDURES. University of Leicester (UoL) Research Governance Office HTA-1006-UoL UNIVERSITY OF LEICESTER STANDARD OPERATING PROCEDURES University of Leicester (UoL) Research Governance Office HTA-1006-UoL Audit of Research Licenced Human Tissue Authority Facilities Within University

More information

STANDARD OPERATING PROCEDURE SOP 310

STANDARD OPERATING PROCEDURE SOP 310 STANDARD OPERATING PROCEDURE SOP 310 DEVELOPMENT OF PARTICIPANT INFORMATION SHEET AND INFORMED CONSENT FORM Version 1.3 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 8 Review date April

More information

Confirming Research Study Capacity and Capability

Confirming Research Study Capacity and Capability Title: Outcome Statement: Written By: Confirming Research Study Capacity and Capability Researchers will be informed about the procedures and requirements for obtaining permission to conduct a research

More information

IMP Management and Accountability

IMP Management and Accountability This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

APPLICANT'S CHECKLIST

APPLICANT'S CHECKLIST APPLICANT'S CHECKLIST Research tissue bank (or other research biobank) REC Ref: Title of Tissue Bank: Applicant's Name: Name of Designated Individual: Please complete this checklist and send it with your

More information

Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products

Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products 1 Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products SECTION TITLE DOCUMENTS 1. Contact List Including details of relevant study site staff, responsible

More information

Standard Operating Procedure for Archiving

Standard Operating Procedure for Archiving Standard Operating Procedure for Archiving SOP name: NWORTH07/19 archiving Version 2 Authorship Team: Angela Gliddon & Rhiannon Whitaker Meeting date reviewed 16 th April 2008 Designated NWORTH member

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Trial Master File & Investigator Site File SOP number: TM 001 SOP category: Trial Management Version number: 03 Version

More information

Investigational Medicinal Product (IMP) Management Standard Operating Procedure

Investigational Medicinal Product (IMP) Management Standard Operating Procedure Reference Number: UHB 040 Version Number: 3 Date of Next Review: 26 Apr 2019 Previous Trust/LHB Reference Number: T 363 Standard Operating Procedure Introduction and Aim This procedure is written to support

More information

Standard Operating Procedure

Standard Operating Procedure Standard Operating Procedure Title: Production and Control of Standard Operating Procedures Purpose The purpose of this SOP is to describe the procedure to be followed to ensure that SOPs are produced

More information

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no:

R&D Manager Hillingdon Hospital. Revision History Effective Date Reason For Change. recommendations Version no: Research as a Participating site STANDARD OPERATING PROCEDURE FOR OVERSIGHT SOP No: P08/PF2 V2 Effective Date: 31 st July 2013 Supersedes: P08/PF2 Revision Date: 31 st March 2014 Author: Position: Approved

More information

Sponsorship of Clinical Research Studies

Sponsorship of Clinical Research Studies Sponsorship of Clinical Research Studies Category: Summary: Equality Impact Assessment undertaken: Policy The UK Policy Framework for Health and Social Care 2017 (UKPF) and The Medicines for Human Use

More information

STUDY CLOSURE AND ARCHIVING

STUDY CLOSURE AND ARCHIVING STUDY CLOSURE AND ARCHIVING DOCUMENT NO.: CR009 v2.0 AUTHOR: Lynn Smith ISSUE DATE: 15 August 2016 EFFECTIVE DATE: 29 August 2016 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research

More information

How to Apply for Ethics (Non-CTIMPs) including Sponsorship

How to Apply for Ethics (Non-CTIMPs) including Sponsorship How to Apply for Ethics (Non-CTIMPs) including Sponsorship Joint Research & Enterprise Office (JREO) St George s University of London Lucy H H Parker Clinical Research Governance Manager Joint Research

More information

Development Safety Update Report Guidance

Development Safety Update Report Guidance Development Safety Update Report Guidance This document provides instructions for the preparation and submission of a Development Safety Update Report (DSUR) for a Clinical Trial of an Investigational

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Training and Development SOP-QMS-007 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s)

More information

Research Governance Policy and Procedure

Research Governance Policy and Procedure Research Governance Policy and Procedure Version: 5 Name of originator/author: Name of executive lead: Date ratified: Review date: APPLICABLE TO: All staff. EXECUTIVE SUMMARY Dr Lisa Austin- University

More information

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual

ISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual The StAmP Trial: A Proof of Principle, double blind, Randomised Placebo-Controlled, Multi Centre Trial of Statins to Ameliorate Early Onset Pre-eclampsia. ISRCTN: 23410175 EudraCT Number: 2009-012968-13

More information

ECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies

ECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies ECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies SOP number: ECTU TM 17 Signature Date Authored by: Holly Ennis, Trial Manager 6 th Sept 2017 Reviewed by: Laura Forsyth, Trial Manager

More information

HRA Statement of Activities

HRA Statement of Activities HRA Statement of Activities for Participating NHS Organisations in England (template version 4.0) For non-commercial studies, one Statement of Activities should be completed as a template for each site

More information

HTA Disposal of Human Tissue SOP. Standard Operating Procedure for the Use and Storage of Human Tissue for the purposes of Research and Teaching

HTA Disposal of Human Tissue SOP. Standard Operating Procedure for the Use and Storage of Human Tissue for the purposes of Research and Teaching Standard Operating Procedure for the Use and Storage of Human Tissue for the purposes of Research and Teaching Version Number : 2 Review Date: September 2015 Author: Lucy Ghali Position Designated Individual

More information

RECRUITMENT AND SELECTION POLICY

RECRUITMENT AND SELECTION POLICY RECRUITMENT AND SELECTION POLICY Document Summary This document outlines the recruitment and selection process in relation to Hospice at Home Carlisle and North Lakeland. This is the final version of this

More information

Management and Accountability of Investigational Medicinal Products in the King s Clinical Research Facility

Management and Accountability of Investigational Medicinal Products in the King s Clinical Research Facility Management and Accountability of Investigational Medicinal Products in the King s Clinical Research Facility Document Detail Document type Standard Operating Procedure CRF-STU-SOP-1: Management and Accountability

More information

Marie-Claire Good, RG and GCP Manager James Rickard, Deputy Chief Pharmacist Technical Services Cheryl Lawrence, Senior Research Pharmacist

Marie-Claire Good, RG and GCP Manager James Rickard, Deputy Chief Pharmacist Technical Services Cheryl Lawrence, Senior Research Pharmacist Standard Operating Procedures (SOP) for: IMP Management BH/QMUL Sponsored CTIMPs SOP Number: 42a Version Number: 3.0 Effective Date: 14 th August 2017 Review Date: 14 th August 2019 Author: Reviewer: Reviewer:

More information

Standard Operating Procedures for HTA samples

Standard Operating Procedures for HTA samples Standard Operating Procedures for HTA Samples Page 1 of 16 Standard Operating Procedures for HTA samples NB the Standard Operating Procedures (SOPs) listed below define the physical laboratory processes

More information

Date: 2 nd June 2010 Version: 3 Page 1 of 16 AND LABELLING (NWORTH 3.08) Principal Author Name: E. Bedson Signature: E. Bedson Date:15/06/10

Date: 2 nd June 2010 Version: 3 Page 1 of 16 AND LABELLING (NWORTH 3.08) Principal Author Name: E. Bedson Signature: E. Bedson Date:15/06/10 Page 1 of 16 STANDARD OPERATING PROCEDURE FOR TRIAL SUPPLIES AND LABELLING (NWORTH 3.08) Approvals Principal Author Name: E. Bedson Signature: E. Bedson Date:15/06/10 Quality Assurance Officer Name: D.

More information

PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES

PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES Version Control Item 19 Items 25, 26 Item 29 Update to the Publication requirements Update of Submission Timetable

More information

Short Title: CCI Biobank

Short Title: CCI Biobank Patient Label Stamp or letterhead of the department Patient Information Donation, Storage and Use of Biological Materials and Collection, Processing and Use of Data of the CCI Biobank, Medical Center -

More information

Guidance on conducting consultations in the HRA Internal HRA guidance only

Guidance on conducting consultations in the HRA Internal HRA guidance only Guidance on conducting consultations in the HRA Internal HRA guidance only Author: Amanda Hunn Date of Release: 19 th February 2015 Version No. & Status: v.1.0 Final Approved by: EMT Supersedes Version:

More information

INDUCTION POLICY AND PROCEDURE

INDUCTION POLICY AND PROCEDURE Summary INDUCTION POLICY AND PROCEDURE New members of staff require an induction period to enable them to settle in to their new place of work. This policy sets out the framework and responsibilities for

More information

Combined trial of an investigational medicinal product and an investigational medical device

Combined trial of an investigational medicinal product and an investigational medical device Welcome to the Integrated Research Application System IRAS Project Filter The integrated dataset required for your project will be created from the answers you give to the following questions. The system

More information

DOCUMENT CONTROL PAGE

DOCUMENT CONTROL PAGE DOCUMENT CONTROL PAGE Title Title: Guidance on Human Tissue Act 2004 consent requirements for the removal, storage and use of human tissue Version: 2 Reference Number: HTA010 Supersedes Supersedes: 1 Description

More information

Trial oversight SOP for HEY-sponsored CTIMPs

Trial oversight SOP for HEY-sponsored CTIMPs R&D Department Trial oversight SOP for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored in a retrieval system

More information

Competence in Clinical Trials the Regulators Perspective.. (Jennifer Martin Senior GCP Inspector, 9 June 2014)

Competence in Clinical Trials the Regulators Perspective.. (Jennifer Martin Senior GCP Inspector, 9 June 2014) Competence in Clinical Trials the Regulators Perspective. (Jennifer Martin Senior GCP Inspector, 9 June 2014) Requirements Statutory Instrument 2004/1031 (as amended) Regulation 28(2): The sponsor (and

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria Question 1: What laws or regulations apply to an application for conducting a clinical

More information

Inspections: an academic perspective

Inspections: an academic perspective Inspections: an academic perspective Patricia Henley Quality and Governance Manager Head, Research Governance & Integrity Office London School of Hygiene & Tropical Medicine Email: patricia.henley@lshtm.ac.uk

More information

PREPARING TO RUN A TRIAL

PREPARING TO RUN A TRIAL PREPARING TO RUN A TRIAL PHASE 1 STUDIES This phase is designed to assess the safety (pharmacovigilance), tolerability, pharmacokinetics, and pharmacodynamics of a drug. STUDY DESIGN Phase I clinical trials

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Archiving and the Destruction of Records SOP-RES-028 Version Number 2 Issue Date 08 th Dec 2015 Effective Date 22 nd January 2016 Review Date 22 nd January

More information

Governance & Compliance Audit Of Human Tissue For Research Purposes Procedure

Governance & Compliance Audit Of Human Tissue For Research Purposes Procedure Version Number: 2 Date of Next Review: 11 TH Oct 2019 Previous Trust/LHB N/A Governance & Compliance Audit Of Human Tissue For Research Purposes Procedure Introduction and Aim The Human Tissue Act 2004

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Audits and Inspections SOP-QMS-004 Version Number 4 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s)

More information

ICH/GCP Guidelines Self-Evaluation Questionnaire

ICH/GCP Guidelines Self-Evaluation Questionnaire THE QUALITY ASSURANCE JOURNAL, VOL. 2, 74 82 (1997) ICH/GCP Guidelines Self-Evaluation Questionnaire The questionnaire below has been designed as a diverting, internal training tool by a group of employees

More information

Author Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document

Author Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document SOP Title: Investigator s Brochure Content, Design, Amendments, Filing & Distribution Author: Clinical Research and Development Office (CRDO) Author Signature: Date: 10 October 2017 The author is signing

More information

PERINAT COLLECTION PLATFORM CHARTER

PERINAT COLLECTION PLATFORM CHARTER PERINAT COLLECTION PLATFORM CHARTER PremUp - Maternité de Port Royal: 53 avenue de l'observatoire - 75014 Paris Tel: 00 33 1 76 53 55 48 - Email: perinatcollection@premup.org Contents 1) ABOUT PERINAT...

More information

TOPIC GUIDE: TEMPLATE FOR TENDER DOCUMENTATION

TOPIC GUIDE: TEMPLATE FOR TENDER DOCUMENTATION TOPIC GUIDE: TEMPLATE FOR TENDER DOCUMENTATION Attached is a template which can be used when competitively tendering. It consists of: Covering Letter - You may wish to make slight amendments. Terms and

More information

University HTA Licence Compliance Quality Manual

University HTA Licence Compliance Quality Manual University HTA Licence Compliance Quality Manual This document together with a set of specified procedures represents the Quality Management System for the control of Human Tissue Authority (HTA) licensable

More information

Standard Operating Procedure for Statistical Reports

Standard Operating Procedure for Statistical Reports Reports_V01.doc Page 1 of 6 Standard Operating Procedure for Statistical Reports SOP ID Number: Effective Date: 22/01/2010 Version Number & Date of Authorisation: V01,15/01/2010 Review Date: 22/01/2012

More information

STANDARD OPERATING PROCEDURE SOP 320. Developing a Research Protocol

STANDARD OPERATING PROCEDURE SOP 320. Developing a Research Protocol STANDARD OPERATING PROCEDURE SOP 320 Developing a Research Protocol Version 2.1 Version date 26.03.2017 Effective date 26.03.2017 Number of pages 14 Review date April 2019 Author NNUH UEA Joint Research

More information

Humber Information Sharing Charter

Humber Information Sharing Charter External Ref: HIG 01 Review date November 2016 Version No. V07 Internal Ref: NELC 16.60.01 Humber Information Sharing Charter This Charter may be an uncontrolled copy, please check the source of this document

More information

Standard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies. SOP Number: UoA-NHSG-SOP-010 Version No: 2

Standard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies. SOP Number: UoA-NHSG-SOP-010 Version No: 2 Standard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies SOP Number: UoA-NHSG-SOP-010 Version No: 2 Author: Date: 27 th March 2015 (Carole Edwards, Lead Research

More information

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE CANCER CENTER SCIENTIFIC REVIEW COMMITTEE The Clinical Scientific Review Committee (SRC) at The Medical College of Wisconsin Cancer Center plays a vital role in protocol review and monitoring to ensure

More information

ABERYSTWYTH UNIVERSITY PROCUREMENT RECORDS RETENTION SCHEDULE

ABERYSTWYTH UNIVERSITY PROCUREMENT RECORDS RETENTION SCHEDULE ABERYSTWYTH UNIVERSITY PROCUREMENT RECORDS RETENTION SCHEDULE Key: Retention period - CFY current financial year CAY current academic year CY current calendar year CTY current tax year Authority RM Records

More information

Research Involving Human Data or Specimens

Research Involving Human Data or Specimens Page 1 of 5 Research Involving Human Data or Specimens Introduction: The Office for Human Research Protections has issued guidance on research involving coded private information or human biological specimens.

More information

Procurement Procedure. (Standard Operating Procedure)

Procurement Procedure. (Standard Operating Procedure) Procedure (Standard Operating Procedure) Procedure Policy : Executive Summary: Policy The Procedure provides guidance on the appropriate procurement process to all Trust Staff and Budget Holders involved

More information

Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE

Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE In completing this form please refer to the attached Notes of Guidance Application for approval of all studies involving Healthy

More information

What is the purpose of the Tissue Bank and the Research it will be used for?

What is the purpose of the Tissue Bank and the Research it will be used for? PARTICIPANT INFORMATION SHEET King s College London Haemato-Oncology Tissue Bank: The Collection and Storage of Blood and Tissue for Use in Future Studies into the Causes, Diagnosis and Treatment of Haematological

More information

PARTNERS HUMAN RESEARCH COMMITTEE. Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review

PARTNERS HUMAN RESEARCH COMMITTEE. Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review PARTNERS HUMAN RESEARCH COMMITTEE Human Tissues: Brief Primer on Research Use and Requirement for Partners IRB Review For the purposes of this Primer, tissue is defined as any biological specimen obtained

More information

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way.

Participant Copy. No. Participation is voluntary. Your decision will not affect your health care at Mayo Clinic in any way. Name and Clinic Number IRB # 08-007049 00 Consent form approved July 16, 2015; This consent valid through July 15, 2016; 1. General Information About This Research Study Study Title: Mayo Clinic Biobank

More information

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents Guidance for s Regulatory File Essential s All principal investigators must maintain a regulatory binder or file system, which contains all study documentation. These records may be reviewed at the time

More information

Records Management Plan

Records Management Plan Records Management Plan Introduction Purpose The purpose of the Records Management Plan template enables a Business Unit to plan their records management activities based on the business units 1,2 or 3

More information

WHO WE ARE Newcastle Theatre Royal Trust Limited manages Newcastle Theatre Royal and City Hall and is a registered charity. We receive no ongoing reve

WHO WE ARE Newcastle Theatre Royal Trust Limited manages Newcastle Theatre Royal and City Hall and is a registered charity. We receive no ongoing reve OUR DATA PROMISE Newcastle Theatre Royal Trust Limited is committed to protecting your privacy and data. We will use the information that we collect about you in accordance with the General Data Protection

More information

RESEARCH GOVERNANCE SITE SPECIFIC ASSESSMENT

RESEARCH GOVERNANCE SITE SPECIFIC ASSESSMENT JAN SINGLETON RESEARCH GOVERNANCE SITE SPECIFIC ASSESSMENT Research is what I'm doing when I don't know what I'm doing. ~Wernher Von Braun When are you approved to commence your research? Your study has

More information

Source And Regulatory Documentation for DMID Clinical Studies

Source And Regulatory Documentation for DMID Clinical Studies Source And Regulatory Documentation for DMID Clinical Studies Walt Jones RN, MPH Nurse Consultant Clinical Monitoring Coordinator OCRA, DMID, NIAID November, 2007 Source Data Defined All information in

More information

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS Catherine Jahrsdorfer, R.N., B.S.N. Director of Clinical Services Office of Clinical Research January 2 & 3, 2012 Learning

More information

HSCIC Audit of Data Sharing Activities:

HSCIC Audit of Data Sharing Activities: Directorate / Programme Data Dissemination Services Project Data Sharing Audits Status Approved Director Terry Hill Version 1.0 Owner Rob Shaw Version issue date 20/04/2016 HSCIC Audit of Data Sharing

More information

Standard Operating Procedure (SOP) Research and Development Office

Standard Operating Procedure (SOP) Research and Development Office Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Creation & Maintenance of an Investigator Brochure SOP Number: 34 Version Number: 1.0 Supercedes: N/A Effective date: August

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Clinical Trial Application Form MEDICINES CONTROL COUNCIL APPLICATION TO CONDUCT A CLINICAL TRIAL Study title Protocol No. Version No. Study Drug MCC Ref. no. (if applicable) MCC Ref number(s) of comparator

More information

Internal Audit. Absence Management. October 2016

Internal Audit. Absence Management. October 2016 October 2016 Report Assessment G A G G G This report has been prepared solely for internal use as part of NHS Lothian s internal audit service. No part of this report should be made available, quoted or

More information

Trial Protocol. Version 1.2. Effective date: 18 May Dr Sarah Duggan, CTU Manager. V May 2010 Update web links.

Trial Protocol. Version 1.2. Effective date: 18 May Dr Sarah Duggan, CTU Manager. V May 2010 Update web links. Trial Version 1.2 Effective date: 18 May 2010 Reviewed by: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Reason for change V1.2 18 May 2010 Update

More information

PHARMACY, MEDICINES & POISONS BOARD

PHARMACY, MEDICINES & POISONS BOARD PHARMACY, MEDICINES & POISONS BOARD PHARMACY GUIDELINES FOR INVESTIGATIONAL DRUGS A. Purpose These guidelines are principally derived and adapted from guidelines from various sources within the SADC region.

More information

Reflection paper on guidance for laboratories that perform the analysis or evaluation of clinical trial samples

Reflection paper on guidance for laboratories that perform the analysis or evaluation of clinical trial samples 1 2 3 26 August 2010 EMA/INS/GCP/532137/2010 GCP Inspectors Working Group 4 5 6 Reflection paper on guidance for laboratories that perform the analysis or evaluation of clinical trial samples Draft Adoption

More information

Key changes in new BCSH Transfusion I.T. Guidelines. Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group

Key changes in new BCSH Transfusion I.T. Guidelines. Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group Key changes in new BCSH Transfusion I.T. Guidelines Debbie Asher EPA Network Transfusion Manager Member, BCSH Guideline Writing Group Membership Joan Jones Head of Quality, Welsh Blood Service Paul Ashford

More information

Volunteer Placement Scheme Policy

Volunteer Placement Scheme Policy Policy NECA promotes and encourages the participation of Volunteers in all areas of its work. NECA recognises the different but equally valuable contribution of Volunteers in complementing the work of

More information

Scotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG

Scotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Scotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Telephone: 0131-465-5679 19 February 2016 Professor Karim Brohi Professor of Trauma Science Queen Mary University of London

More information

Standard Operating Procedures (SOPs)

Standard Operating Procedures (SOPs) Organizational Strategies for Clinical Trials Standard Operating Procedures (SOPs) SUSAN JACKSON, MPA UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL CENTER FOR GASTROINTESTINAL BIOLOGY AND DISEASE UNC CENTER

More information

Date ratified June, Implementation Date August, Date of full Implementation August, Review Date Feb, Version number V02.

Date ratified June, Implementation Date August, Date of full Implementation August, Review Date Feb, Version number V02. Document Title Reference Number Lead Officer Author(s) Ratified by Disputes Policy NTW(HR)07 Lisa Crichton-Jones Acting Executive Director of Workforce and Organisational Development Jacqueline Tate-Workforce

More information

CODE OF PRACTICE FOR RESEARCH

CODE OF PRACTICE FOR RESEARCH CODE OF PRACTICE FOR RESEARCH Dr Diana Leighton REF Manager Professor Andy Young Director of Research & Innovation Services Version 1.0 - September 2010 First approved Academic Board 27 September 2010

More information

9. Chapter 9: Data Management Procedures

9. Chapter 9: Data Management Procedures 9. Chapter 9: Data Management Procedures 9.1 General Instructions for Completing Forms All ENRICHD study data should be recorded on official ENRICHD data collection forms provided by the coordinating center.

More information

NHS Research Ethics Approval the process

NHS Research Ethics Approval the process NHS Research Ethics Approval the process Dr Sheila A Simpson 27 May 2008 ETHICS The process of determining what is right and wrong Personal code of conduct based on respect for one's self, others, and

More information

ZOLL Document Number: 90E0004 Page 5 of 15 Maintenance of Quality Records

ZOLL Document Number: 90E0004 Page 5 of 15 Maintenance of Quality Records ZOLL Number: 90E0004 Page 5 of 15 1. INTRODUCTION 1.1 Purpose 1.2 Scope The purpose of this document is to provide guidance regarding the identification of a quality record and the documentation practices

More information

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17 SOP #: INV-100 Page: 1 of 5 1. POLICY STATEMENT: DF/HCC research pharmacies follow a standard set of policy requirements for clinical trials. 2. BACKGROUND: None 3. RESPONSIBLE PERSONNEL: 3.1. Research

More information

Source Documents and Regulatory Binders October 6, 2016

Source Documents and Regulatory Binders October 6, 2016 Source Documents and Regulatory Binders October 6, 2016 Lisa Wilson, Regulatory Lead, Clinical Trials Office and Mark Alger, CRC, Clinical Trials Office Essential Documents AKA: the stuff in the Reg Binder

More information

External Recruitment Process

External Recruitment Process External Recruitment Process This document should help you to understand the full recruitment process from end to end. Please use the External Recruitment Process Flowchart to understand each stage of

More information

Packaging, Labelling and Transport of Organs in Deceased and Living Donation and Transplantation. Summary of Significant Changes

Packaging, Labelling and Transport of Organs in Deceased and Living Donation and Transplantation. Summary of Significant Changes This National Operating Procedure replaces: NOP003 Summary of Significant Changes Effective: 6 th December 2016 Document updated to reflect changes in organ packaging and labelling including minor changes

More information

Project Title, Ethics and Risk Assessment

Project Title, Ethics and Risk Assessment School of Law Project Title, Ethics and Risk Assessment The purpose of this form is to confirm that supervisor and student have agreed on an appropriate title for the student s project and addressed any

More information

Submitting a CTA application to the MHRA

Submitting a CTA application to the MHRA This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

GOVERNANCE STRATEGY October 2013

GOVERNANCE STRATEGY October 2013 GOVERNANCE STRATEGY October 2013 1. Introduction 1.1. The Central Manchester University Hospitals NHS Foundation Trust believes that the role of the governing body is pivotal to the success of the Trust.

More information

NHS National Survey of Adult Inpatients

NHS National Survey of Adult Inpatients NHS National Survey of Adult Inpatients Approved Contractor 2006-8 Guidance Material from Snap Surveys August 07 Snap SurveyShop proposal (Healthcare Commission / 1055R/ Staff v03) 1 1. ORGANISATION Snap

More information

Trust Board Meeting: Wednesday 8 July 2015 TB

Trust Board Meeting: Wednesday 8 July 2015 TB Trust Board Meeting: Wednesday 8 July 2015 Title NIHR Reporting of R&D Metrics Status History A paper for information The Trust Management Executive received an update on the performance of the Trust with

More information

FDA Sponsor and Investigator Responsibility Checklist

FDA Sponsor and Investigator Responsibility Checklist FDA Sponsor and Investigator Responsibility Checklist Principal Investigator: Study Name: CPHS #: IND/IDE #: Name of IND/IDE holder: The following checklist is created based on the Sponsor and Investigator

More information

This policy supersedes the following which much now be destroyed:

This policy supersedes the following which much now be destroyed: Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Research Governance Policy NTW(O)47 Medical Director Simon Douglas, Senior Manager for Research Innovation and

More information

The Newcastle upon Tyne Hospitals Foundation NHS Trust. Employment Policies and Procedures

The Newcastle upon Tyne Hospitals Foundation NHS Trust. Employment Policies and Procedures The Newcastle upon Tyne Hospitals Foundation NHS Trust Employment Policies and Procedures Staff Leaving the Trust or Moving within the Trust Procedure Version No.: 5.6 Effective Date: 13 December 2017

More information

Standard Operating Procedures Guidelines for Good Clinical Practice

Standard Operating Procedures Guidelines for Good Clinical Practice SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA

More information

REQUEST FOR PROPOSAL (RFP) FOR CONTRACT MANAGEMENT SYSTEM ISSUED BY THE RFP INFORMATION

REQUEST FOR PROPOSAL (RFP) FOR CONTRACT MANAGEMENT SYSTEM ISSUED BY THE RFP INFORMATION REQUEST FOR PROPOSAL (RFP) FOR CONTRACT MANAGEMENT SYSTEM ISSUED BY THE NEW YORK ehealth COLLABORATIVE CONTACT NAME EMAIL ADDRESS SUBMISSION DEADLINE RFP INFORMATION NYeC RFP rfpcontact@nyehealth.org September

More information

annex 3. Template consent form for biobanking

annex 3. Template consent form for biobanking annex 3. Template consent form for biobanking This template is based on Public Population Project in Genomics and Society (P3G) database resources. General considerations The information brochure and consent

More information

COMPUTER SYSTEMS VALIDATION

COMPUTER SYSTEMS VALIDATION COMPUTER SYSTEMS VALIDATION DOCUMENT NO.: POL007 v1.0 AUTHOR: Lorn Mackenzie ISSUE DATE: 04 AUG 2017 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint

More information

Storage of Clinical Trials Materials and Investigational Medicinal Products

Storage of Clinical Trials Materials and Investigational Medicinal Products York Foundation Trust R&D Unit Standard Operating Procedure Pharm/S47 Storage of Clinical Trials Materials and Investigational Medicinal Products IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE

More information

HSCIC Audit of Data Sharing Activities:

HSCIC Audit of Data Sharing Activities: Directorate / Programme Data Dissemination Services Project Data Sharing Audits Status Approved Director Terry Hill Version 1.0 Owner Rob Shaw Version issue date 20/04/2016 HSCIC Audit of Data Sharing

More information